Truist Financial assumed coverage on shares of Treace Medical Concepts (NASDAQ:TMCI – Get Rating) in a research report released on Monday morning, The Fly reports. The firm issued a buy rating and a $33.00 price target on the stock. Other equities analysts have also recently issued reports about the company. BTIG Research increased their target […]
Allspring Global Investments Holdings LLC increased its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) by 278.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 478,815 shares of the company’s stock after buying an additional 352,208 shares during the period. Allspring Global […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director James T. Treace sold 30,313 shares of the company’s stock in a transaction that occurred on Wednesday, May 25th. The stock was sold at an average price of $15.35, for a total value of $465,304.55. Following the transaction, the director now directly owns 1,356,128 shares of […]
Roubaix Capital LLC purchased a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) during the 4th quarter, Holdings Channel.com reports. The fund purchased 305,720 shares of the company’s stock, valued at approximately $5,699,000. Treace Medical Concepts makes up 3.5% of Roubaix Capital LLC’s investment portfolio, making the stock its 3rd biggest holding. […]